This is an interesting article from Pharmalot that talks about the deal between Sanofi and Medco Health Solutions where the latter wil help design clinical trials in the future keepign the payers interests in mind.
The move reflects a growing awareness among drugmakers that designing and testing a compound for FDA approval is no longer the only key hurdle to winning sales and market share. Medco will provide input on clinical trial design, help develop comparative effectiveness data and review usage of existing medications to improve patient adherence.
Bascially, the drug not only needs to work, it must represent some tanglible benefit over any drugs that precede it for a particular indication and it must be cost effective. The bar has been raised and at least Sanofi is taking steps to enlist a partner in providing solutions at the trial design and executions phase to make it more market competitive -- which is a good thing.
Posted by Bruce Lehr June 26th 2011.